Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...

The company announced that it now expects a loss from operations of approximately $230 million and a net loss of roughly $228 ...

Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...

Moderately bullish activity in Oscar Health (OSCR), with shares up 26c, or 1.8%, near $14.96. Options volume roughly in line with average with ...

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Oscar Health, Inc. (NYSE:OSCR) is a US based healthcare technology company. The one-month return of Oscar Health, Inc. (NYSE:OSCR) was -2.16%, and its shares gained 3.08% of their value over the last ...

Oscar Health, Inc. looks almost absurdly undervalued at a market cap of ~$620m. The company has >$3bn cash and is forecasting revenues of >$6bn in FY23 and losses of ; $200m.